Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Advances in Radiation Oncology
|
April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Advances in Radiation Oncology
|
November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinic
Paul J Keall, Jeremy Booth, Thomas Eade, et al.
Clinical and Translational Radiation Oncology
|
May 13, 2020
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
Alex Dunlop, Adam Mitchell, Alison Tree, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 29, 2021
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology
Stefanie Corradini, Filippo Alongi, Nicolaus Andratschke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2026
Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study
Sian Cooper, Sophie Alexander, Charlotte Cherry, et al.
JNCI Cancer Spectrum
|
October 3, 2023
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response
Chris Parker, Nina Tunariu, Holly Tovey, et al.
Clinical and Translational Radiation Oncology
|
October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation
Julia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical and Translational Radiation Oncology
|
February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT
Angela Pathmanathan, Suneil Jain, John Staffurth, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
August 18, 2025
Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care
Elena Moreno-Olmedo, Kasia Owczarczyk, Eliot Chadwick, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Advances in Radiation Oncology
|
April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Advances in Radiation Oncology
|
November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinic
Paul J Keall, Jeremy Booth, Thomas Eade, et al.
Clinical and Translational Radiation Oncology
|
May 13, 2020
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
Alex Dunlop, Adam Mitchell, Alison Tree, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 29, 2021
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology
Stefanie Corradini, Filippo Alongi, Nicolaus Andratschke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2026
Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study
Sian Cooper, Sophie Alexander, Charlotte Cherry, et al.
JNCI Cancer Spectrum
|
October 3, 2023
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response
Chris Parker, Nina Tunariu, Holly Tovey, et al.
Clinical and Translational Radiation Oncology
|
October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation
Julia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical and Translational Radiation Oncology
|
February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT
Angela Pathmanathan, Suneil Jain, John Staffurth, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
August 18, 2025
Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care
Elena Moreno-Olmedo, Kasia Owczarczyk, Eliot Chadwick, et al.
Page
of 7